FDA NDC Directory · JSON-LD · Markdown

Cambia

NDC 13913-012 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SOLUTION

Generic namediclofenac potassium
Labeler / ManufacturerAssertio Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022165
Dosage form / routePOWDER, FOR SOLUTION · ORAL
Active ingredientsDICLOFENAC POTASSIUM (50 mg/1)
Marketing started20160310
Package count2

External sources

Source: openFDA. Public-domain (CC0).